Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 29 July 2024

The Committee for Medicinal Products for Human Use (CHMP) is responsible for preparing the European Medicines Agency's opinions on all questions concerning human medicines.
EventHumanReferrals

Latvian is available via eTranslation, the European Commission's machine translation service.

Translate to Latvian | Important information about machine translation

Date

, -

Vieta

Online
European Medicines Agency, Amsterdam, the Netherlands

Documents

Agenda of the extraordinary CHMP meeting 29 July 2024

Reference Number: EMA/CHMP/350070/2024

English (EN) (201.91 KB - PDF)

Pirmo reizi publicēts:
Skatīt

Start of Union reviews adopted during the extraordinary CHMP meeting of 29 July 2024

Adopted Reference Number: EMA/348616/2024

English (EN) (105.83 KB - PDF)

Pirmo reizi publicēts:
Skatīt

Share this page